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Forty Escherichia coli strains isolated primarily from neonatal meningitis, urinary tract infections and feces
were screened for the presence of virulence genes with a newly developed microarray on the array tube format.
A total of 32 gene probes specific for extraintestinal as well as intestinal E. coli pathotypes were included.
Eighty-eight percent of the analyzed strains were positive for the K1-specific probe on the microarray and could
be confirmed with a specific antiserum against the K1 capsular polysaccharide. The gene for the hemin
receptor ChuA was predominantly found in 95% of strains. Other virulence genes associated with K1 and
related strains were P, S, and F1C fimbriae specific for extraintestinal E. coli, the genes for aerobactin, the
-hemolysin and the cytotoxic necrotizing factor. In two strains, the O157-specific catalase gene and the gene
for the low-molecular-weight heat-stable toxin AstA were detected, respectively. A total of 19 different virulence
gene patterns were observed. No correlation was observed between specific virulence gene patterns and a
clinical outcome. The data indicate that virulence genes typical of extraintestinal E. coli are predominantly
present in K1 strains. Nevertheless, some of them can carry virulence genes known to be characteristic of
intestinal E. coli. The distribution and combination of virulence genes show that K1 isolates constitute a
heterogeneous group of E. coli.
Escherichia coli is the most common causative agent of
gram-negative neonatal bacterial meningitis and sepsis. Bacte-
rial meningitis is a devastating disease and the major cause of
high neonatal mortality and morbidity (40). More than half of
the survivors develop long-term neurological sequelae, includ-
ing seizure disorders, hydrocephalus, physical disability, devel-
opmental delay, and hearing loss (41). Most infections occur in
the first month of life with a frequency of 0.22 to 2.66 per 1,000
live births worldwide (13, 34).
The development of sepsis and meningitis in the neonate
depends on several risk factors in both the infant and the
mother, as well as on the virulence of the pathogen. Prematu-
rity, prolonged rupture of membranes, and low birth weight
but also perinatal, intrauterine infections and maternal urinary
tract infections are strongly associated with neonatal meningi-
tis. The mode of infection of the neonate may be either he-
matogenous (transplacental) or directly through aspiration or
inhalation of the pathogen (34). An early onset of neonatal
bacterial meningitis (within the first week of life) indicates
vertical transmission, whereas later onset is mainly caused by
nosocomial infection.
It is known that strains possessing the K1 capsular polysac-
charide are responsible for approximately 80% of E. coli neo-
natal bacterial meningitis cases and are strongly associated
with infections occurring in the first 3 weeks of life rather than
in older infants (16, 22, 36). Moreover, E. coli K1 strains
belong to the normal flora and are detected in 20 to 40% of
rectal swab cultures from healthy infants, children, and adult
women as well as in vaginal swabs (27, 36).
The K1 encapsulated pathogen is important for bacteremia
and possesses the ability to cross the blood-brain barrier (19,
20, 35). The molecular pathophysiology of meningitis is com-
plex and not completely understood. Pathogenic E. coli is de-
fined by a number of major virulence factors, including attach-
ment functions, host cell surface-modifying factors, invasins, and
different toxins and secretion systems (for a recent review, see
reference 17). Based on the virulence mechanism, epidemiol-
ogy, and clinical presentation, E. coli strains can be divided into
two major categories, intestinal and extraintestinal pathogens.
The first category comprises various pathotypes, including en-
terotoxigenic E. coli, enteropathogenic E. coli, enteroinvasive
E. coli, enteroaggregative E. coli, and Shiga toxin-producing
E. coli, comprising the subgroup of enterohemorrhagic E. coli.
Extraintestinal pathogenic E. coli has been categorized mainly
into uropathogenic E. coli and neonatal meningitis-causing
E. coli.
The genome of E. coli shows a high plasticity, which enables
it to gain or lose genes or modify their loci on the genome at
a relatively high frequency (10, 31). Contributing to that are
virulence plasmids and the chromosomal pathogenicity islands,
which are mobile genetic elements (6, 12). This particular
plasticity allows E. coli strains to share virulence genes within
the species at a high rate, a process called lateral gene transfer.
This allows the formation of new pathotypes with new viru-
lence combinations (38).
Numerous phenotypic and genotypic methods have been
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employed to detect, classify, and type pathogenic E. coli strains
for clinical diagnosis, epidemiological investigations, or routine
surveillance. Serotyping is the most common method used for
identification of virulent E. coli clones. Specific serogroups can
be associated reproducibly with certain clinical syndromes, as
is the case with K1 strains. However, with serotyping, patho-
genic strains are only indirectly identified, and it does not
always correlate to virulence. The PCR technique helps to
determine the presence of certain genes, but its high specificity
makes it impossible to detect variants of genes. Moreover, the
throughput of PCR methods is relatively low since only a few
genes can be detected in a single reaction.
Recently, the very promising method of DNA array analysis
was introduced to provide information about the presence of
virulence genes in the E. coli genome. This technology has
been applied with membrane arrays as well as glass arrays in
various formats ranging from low density with few genes to
higher density arrays including hundreds of probes (4, 10, 23,
42). Usually, the use of those techniques is labor intensive,
time consuming, and quite expensive, which make them useful
only for research laboratories and almost nonapplicable for
routine diagnostic purposes.
An appropriate and fast detection of the virulence genes
present in E. coli would help in defining the pathotypes of
bacteria and could improve diagnostics, prevention, and sur-
veillance. For this aim we have established a prototype diag-
nostic microarray test including a set of known E. coli virulence
genes. The technique was established with reference strains
and evaluated for diagnostics by screening a series of E. coli K1
strains to investigate the virulence gene pattern of such iso-
lates.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and genomic DNA extraction. A total of
40 E. coli strains isolated from clinical cases (predominantly from newborn
babies with meningitis) or previously typed as K1 isolates from sepsis, urinary
tract infection, or feces were analyzed (Table 1). Strains previously used for the
development of a membrane (23) or glass-slide based array system (42) and
described there were included for validating the new microarray (Table 3). In
addition, the following reference strains were used: bovine enterotoxigenic E.
coli JF2762 (B44; fhu fim stI K99), porcine enterotoxigenic E. coli JF1264
(eltI cfa/II hly K88), human enterotoxigenic E. coli DS15-1 (eltI fhu
cfa/II fim stI ast cof lng), human Shiga toxin-producing E. coli N2611-99
(stx1 fhu cnf fim iuc ast cdt), and enterohemorrhagic E. coli O157:H7
(EDL933; stx1 stx2 fhu eae fim ehx ast chu katP). The E. coli K-12
strain XL1 Blue (Stratagene, Amsterdam, The Netherlands) was used as a
nonpathogenic negative control.
For probe construction of the K88 and K99 fimbrial genes, strains JF1264 and
JF2762 were used, respectively. All strains were grown aerobically at 37°C over-
night on trypticase soy agar plates containing 5% sheep blood (Oxoid, Wesel,
Germany). E. coli DH5 was used as a host strain for cloning and propagation
of plasmids. Genomic DNA was isolated with the E.Z.N.A bacterial DNA kit
(PEQLAB Biotechnologie GMBH, Erlangen, Germany) or by the method de-
scribed by Pitcher et al. (33). All DNA samples were treated with RNase.
Agglutination. Overnight cultures of E. coli were serotyped by agglutination
with a K1-specific horse antiserum (29).
Construction of an E. coli virulence gene array. The array was generated with
a total of 32 probes. Twenty-eight of the probes have been previously described
(23, 42). The remaining four probes contain parts of additional E. coli virulence
factors, the cytolethal distending toxin gene (cdtA), the catalase-peroxidase gene
(katP), the K88 pilin gene, and the K99 pilin gene, and were constructed in this
study. The fragments of genes were amplified by PCR with genomic DNA. The
primers used for amplification are listed in Table 2. Details of probe construction
are given in the Results section. The primers were selected on the basis of
available DNA sequences. Amplicons were purified with the High Pure PCR
Product Purification kit (Roche Diagnostic, Mannheim, Germany), digested with
the appropriate enzyme (Roche), and cloned into plasmid pBluescript II SK ()
(Stratagene).
Ultrapure PCR fragments used for array printing were produced as described
previously (23). In short, fragments were cut out from the plasmid by corre-
sponding restriction enzymes. The fragments were purified twice over agarose
gels in order to eliminate plasmid contamination that would result in nonspecific
hybridization signals. These doubly purified inserts were then used for PCR
amplification of fragments in amounts suitable for spotting. The PCR products
were purified and array printing as well as assembly of the array tubes containing
the E. coli specific virulence genes was done by Clondiag Chip Technologies
GmbH, Jena, Germany (www.clondiag.com).
Sequencing. For quality control, all clones were further verified by sequencing
with the BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystem, Fos-
ter City, Calif.) according to the supplier’s guidelines with either the T3 or T7
vector matching primers on an automated ABI Prism 3100 genetic analyzer
(Applied Biosystems). Comparisons of DNA sequences in the EMBL and Gen-
Bank databases were performed with BLAST (3).
DNA labeling. For the random amplification and labeling of total genomic
DNA, an adapted method of Bohlander et al. (7) modified by DeRisi Laboratory
was followed (www.microarrays.org/pdfs/Round_A_B_C.pdf). The whole proce-
dure consisted of three rounds of enzymatic reactions. In a first round approx-
imately 0.1 to 0.5 g of genomic DNA was mixed with 0.5 l of 5 Sequenase
reaction buffer (supplied with Sequenase; USB, Cleveland, Ohio) and 0.5 l of
TABLE 1. E. coli isolates analyzed in the study
Strain Origin or clinicalsettinga
K1
agglutination
Pattern
no.b
JF2840 NBM  12
JF2841 NBM  13
JF2842 NBM  15
JF2983 NBM  5
JF2984 NBM  7
JF2985 NBM  11
JF2986 NBM  17
JF2987 NBM  20
JF2988 NBM  7
JF2989 NBM  23
JF2990 NBM  20
JF2991 NBM  21
JF3051 NBM  7
JF2843 Sepsis  11
JF2993 Sepsis  22
JF2994 Sepsis  18
JF2844 UTI  13
JF2845 UTI  2
JF3038 UTI  7
JF3049 UTI  10
JF3034 Appendicitis  11
JF2837 Feces  5
JF2838 Feces  1
JF2839 Feces  16
JF3035 Feces  14
JF3036 Feces  14
JF3037 Feces  7
JF3039 Feces  7
JF3041 Feces  7
JF3046 Feces  7
JF3053 Feces  19
JF3044 Animal  3
JF3048 Animal  13
JF3052 Animal  7
JF3054 Animal  3
JF3040 Clinical isolate  8
JF3042 Clinical isolate  3
JF3043 Clinical isolate  4
JF3045 Clinical isolate  9
JF3050 Clinical isolate  6
a NBM, newborn bacterial meningitis; UTI, urinary tract infection.
b Corresponding to the patterns described in Table 4.
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the random primer A (5-GTT TCC CAG TCA CGA TCN NNN NNN NN) (40
M), where N is any nucleotide. The solution was denatured for 2 min at 94°C
with a thermal cycler (GeneAmp PCR System) and rapidly cooled down to 10°C
and held for 5 min. At this point 1.25 l of Sequenase mix was added. The
Sequenase mix was prepared for four reactions and consisted of 1 l of 5
Sequenase reaction buffer, 1.5 l of 3 mM deoxynucleoside triphosphates, 0.75
l of 0.1 M dithiothreitol, 1.5 l of bovine serum albumin (500 g/l), and 0.4
l of Sequenase version.2 DNA polymerase (13 U/l). The DNA was randomly
amplified at temperatures raising from 10°C to 37°C for 8 min and then kept at
37°C for 8 min before it was rapidly heated to 94°C for 2 min. The mixture was
cooled down again to 10°C and kept at this temperature for 5 min while adding
0.3 l of Sequenase diluted 1:4 in Sequenase enzyme dilution buffer (supplied
with Sequenase). The reaction was repeated with temperatures rising from 10°C
to 37°C for 8 min and kept at 37°C for 8 min. Finally, 11 l of diluted water was
added to each sample.
In the second round, randomly obtained fragments were amplified with spe-
cific primer B (5-GTT TCC CAG TCA CGA TC). The reaction was performed
as follows: 1 PCR buffer (supplied with Taq DNA polymerase), 1 mM de-
oxynucleoside triphosphate, 2.5 U of Taq DNA polymerase (Roche), 40 pmol of
primer B, 7.5 l of template from the first round, and deionized water up to a
final volume of 50 l. PCR conditions were as follows: 25 cycles at 94°C for 30 s,
40°C for 30s, 50°C for 30 s, and 72°C for 2 min. For quality control, 5.0 l of the
PCR product was run on a 1% agarose gel. In the last step, 3.5 l of this PCR
product was used for the labeling reaction. PCR was run under the same con-
ditions as in the previous step, with 1 PCR buffer, 100 M each dATP, dCTP,
and dGTP, 65 M dTTP, 60 M biotine-16-dUTP (Roche), 2.5 U of Taq DNA
polymerase, 40 pmol of primer B, and deionized water up to 25 l.
Array hybridization. The array tubes were placed in a thermomixer (Eppen-
dorf, Hamburg, Germany), washed three times with 500 l of deionized water
and once with 500 l of hybridization buffer (Clondiag Chip Technologies), each
time at 55°C for 5 min and 550 rpm. Usually, 10 l of labeled genomic DNA was
diluted in 100 l of hybridization buffer (Clondiag Chip Technologies), dena-
tured at 94°C for 5 min, cooled down on ice for 2 min, and added to the array
tubes. The hybridization was carried out at 55°C overnight by gentle shaking in
a hybridization oven. After hybridization the array tubes were washed with 500
l of 2 sodium chloride-sodium citrate (SSC)--0.2% sodium dodecyl sulfate
(SDS) at 30°C for 5 min in the thermomixer at 550 rpm, followed by 500 l of 2
SSC at 20°C for 5 min at 550 rpm and finally with 0.2 SSC at 20°C for 5 min at
550 rpm. A blocking step was carried out with 2% (wt/vol) milk powder in 100 l
of 6X SSPE–0.005% Triton at 30°C for 15 min. Poly-horseradish peroxidase-
streptavidin conjugate (100 pg/l) was added in 100 l of 6 SSPE--0.005%
Triton and incubated at 30°C for 15 min at 550 rpm. The previous washing
procedure was repeated after blocking with 2 SSC--0.01% Triton, 2 SSC, and
0.2 SSC. Array tubes were kept in the last buffer at 20°C until further process-
ing.
Visualization of hybridization was achieved by adding 100 l of peroxidase
substrate (Clondiag Chip Technologies) to the array tubes, and detection of
signals was done in the array tube reader (ATR01, Clondiag Chip Technologies).
Signals were recorded at 25°C for 15 min. The data were then analyzed with the
IconoClust version 2.2 software (Clondiag Chip Technologies).
RESULTS
Probe construction. In addition to the 28 virulence gene
probes developed earlier (23, 42), four new probes were con-
structed for the array tube in order to broaden the spectrum of
detectable virulence genes. They include cdtA and katP, found
in the highly pathogenic enterohemorrhagic E. coli strains, and
probes for the K88 and K99 fimbrial genes of two important
animal pathogens. Plasmid pJFFECCDT, which contains the
cdtA gene, specific for the cytolethal distending toxin of en-
terohemorrhagic E. coli strains (15), was generated by cloning
a 600-bp fragment amplified from enterohemorrhagic E. coli
N2110_01 with the primers ECCDT-L and ECCDT-R (Table
2). The PCR fragment was digested with EcoRI and cloned
into the corresponding site of pBluescript. The gene probe was
then amplified from the purified EcoRI insert of plasmid
pJFFECCDT with primers ECCDT-L and ECCDT-R.
The plasmid pJFFECKAT was constructed by amplifying a
700-bp fragment of the katP gene with primers ECKAT-L and
ECKAT-R (Table 2) from strain N2110_01. The fragment
specific for strains of the O157 serotype (9) was digested with
EcoRI and cloned accordingly. Preparation of the specific katP
probe was achieved by cutting out the insert with EcoRI and
amplifying the purified fragment with primers ECKAT-L and
ECKAT-R. Plasmid pJFFECK88 contains an insert specific for
porcine enterotoxigenic E. coli K88 strains, causing diarrhea
and edema disease in piglets (11). It contains the 600-bp am-
plicon generated by PCR with strain JF1264 and primers
ECK88-L and ECK88-R (Table 2), digestion with XbaI and
XhoI, and cloning into pBluescript. The probe was then gen-
erated by excision with XbaI and XhoI followed by PCR on the
purified insert with primers ECK88-L and ECK88-R. Finally,
pJFFECK99, specific for K99 fimbriae of bovine enterotoxi-
genic E. coli strains (11), was generated with primers ECK99-L
and ECK99-R (Table 2) and DNA from strain JF2762. The
resulting PCR product was cloned into the EcoRI site of
pBluescript. After digestion with EcoRI and purification of the
insert, the probe was amplified with primers ECK99-L and
ECK99-R.
Evaluation of the diagnostic microarray. The performance
of the array tube system was tested with a series of reference
strains (Table 3). Analysis of the data with the IconoClust
software allowed the definition of threshold values for positive
signals. Every spot showing an intensity higher than the deter-
mined local background was counted as a positive signal. All
the probes spotted on the array tube showed up (Table 3). For
the gene of the heat-labile toxin II, no reference strain con-
taining this gene was available.
As an example, the array tube hybridization with the refer-
ence strains enterohemorrhagic E. coli EDL933, uropatho-
genic E. coli J96, and K1 isolate JF3053 analyzed in this study
is shown in Fig. 1. Hybridization results were further compared
with the other methods established for broad-range virulence
TABLE 2. Primers used for amplification of virulence gene probes
Plasmid Gene Primer Sequence Length (nt) Reference Accession no.
pJFFECCDT cdtA ECCDT-L GCGGAATTCTCAAGTAGAGGGAGGACCA 598 15 AJ508930
ECCDT-R GCGGAATTCTGGCTTAACAATAGTGGC
pJFFECKAT katP ECKAT-L GCGGAATTCACATTTCGTGTGACTGATT 699 9 X89017
ECKAT-R GCGGAATTCATCCGAGGCATATACTTCT
pJFFECK88 K88 ECK88-L2 TGCTCTAGAATCGGTGGTAGTATCACTGC 595 11 M25302
ECK88-R2 CCGCTCGAGAACCTGCGACGTCAACAAGA
pJFFECK99 K99 ECK99-L GCGGAATTCTGCGACTACCAATGCTTCTG 450 11 M35282
ECK99-R GCGGAATTCTATCCACCATTAGACGGAGC
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gene detection. All spots expected to be positive from the
membrane (23) and the glass-slide format (42) could be de-
tected with the conditions optimized for the array tube. There
was one discrepancy for the F1C probe signal in strain IHE
3034. Whereas there was a clear positive signal on the mem-
brane (23) as well as the array tube, this gene was missed in this
strain with the classical glass-slide microarray (42). However,
PCR analysis with F1C gene-specific primers (23) confirmed
that the gene is present in this strain. Similarly, the somewhat
surprising positive signal for the aerobactin gene in strain
N2611-99 could be confirmed by PCR.
Screening of clinical isolates. A total of 40 strains isolated
from clinical cases or previously typed as K1 by agglutination
were screened with the diagnostic microarray. The results are
summarized in Table 4. All strains showed signals with the
positive controls for 16S rRNA (rrs) and type 1 fimbriae
(fimA). The fhuA gene encoding the ferrichrome iron receptor
of the low-efficiency iron transport system was positive for 31
strains (78%). Thirty-five of the 40 strains showed a clearly
positive signal with the K1-specific probe (88%). All these
positive strains could be confirmed phenotypically by aggluti-
nation with a K1-specific antiserum. Five strains were negative
for the K1 capsule genetically as well as by the agglutination
assay. One of the non-K1 strains did not show any positive
signal with the virulence probes on the microarray (pattern 23,
Table 4).
FIG. 1. Microarray results of different clinical Escherichia coli strains with the array tube. Panel A: hybridization with the uropathogenic
reference strain E. coli J96. Panel B: hybridization with JF3053, isolated from a case of neonatal meningitis. Panel C: hybridization with the
enterohemorrhagic reference strain EDL933. The DNA probe arrangement on the array tube is as follows: A2-4, K88 fimbria (K88); A5-7, K99
fimbria (K99); B2 and C10-11, hemin receptor (chuA); B3-5, 16S rRNA gene (rrs); B6-8, cytolethal distending toxin (cdtB); B9-11, catalase-
peroxidase (katP); C2-3, D11, heat-stable toxin (astA); C4-6, colonization factor antigen III (cofA); C7-9, longus pilus (lngA); D2-4, S fimbria (sfaS);
D5-7, -hemolysin (hlyA); D8-10, enterohemorrhagic E. coli hemolysin (ehxA); E2 and F10-11, K5 capsule (kfiB); E3-5, P fimbria (papA); E6-8,
S fimbria (sfaA); E9-11, heat-stable toxin (stIA/B); F2-3 and G11, invasion plasmid antigen (ipaH); F4-6, aerobactin (iucC); F7-9, K1 capsule
(neuC); G2-4, intimin (eae); G5-7, F1C fimbria (foc); G8-10, type 1 fimbria (fimA); H2 and I10-11, bundle-forming pilus (bfpA); H3-5, colonization
factor antigen I (cfa/I); H6-8, cytotoxic necrotizing factor (cnf); H9-11, colonization factor antigen II (cfa/II); I2-3 and J11, heat-labile toxin II
(eltIIA); I4-6, aggregative adhesion fimbria (aaf/I); I7-9, ferrichrome-iron receptor (fhuA); J2-4, Shiga toxin 1 (stx1); J5-7, Shiga toxin 2 (stx2); J8-10,
heat-labile toxin I (eltIA); columns 1 and 12, biotin-modified DNA sequence dots.
TABLE 4. Virulence gene patterns of E. coli K1 and related strains analyzed in this studya
Gene probe
Pattern no.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
K1 capsule (neuC) ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
P fimbria (pap) ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
S fimbria (sfaA) ● ● ● ● ● ● ● ● ●
S fimbria (sfaS) ● ● ● ● ● ● ● ● ●
FIC fimbria (foc) ● ● ● ● ● ● ● ● ● ● ● ● ●
-Hemolysin (hlyA) ● ● ● ● ● ● ● ●
Cytotoxic necrotizing factor (cnf) ● ● ● ● ●
Aerobactin (iucC) ● ● ● ● ● ● ● ●
Hemin receptor (chuA) ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
K5 capsule (kfiB) ●
Heat-stable toxin (astA) ●
Catalase (katP) ●
16S rRNA gene (rrs) ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
Type 1 fimbria (fimA) ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
Ferrichrom-iron receptor (fhuA) ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
a Only probes hybridizing with one or more strains are listed. Negative probes are mentioned in the text. Positive signals are indicated by a dot.
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The gene for the cytotoxic necrotizing factor was found in six
strains (15%). The probe for F1C fimbriae (foc) showed pos-
itive signals in 19 strains (48%), the one for the P fimbriae in
26 (65%), and the S fimbrial genes sfaS and sfaA were con-
comitantly detected in 14 (35%) of the isolates. The -hemo-
lysin gene could be identified in nine (23%) strains. Genes
indicating high-efficiency iron transport systems could be
found in 20 (50%) strains in the case of the aerobactin gene
iucC and in 38 (95%) strains in the case of the hemin receptor
gene chuA. A single strain was positive for the katP gene,
another one for the astA gene, and one of the non-K1 strains
hybridized with the gene specific for the K5 capsule (kfiB). The
positive signals for the probes katP and astA, specific for in-
testinal pathogens, detected in strains JF3050 and JF2994,
respectively, were confirmed by PCR.
Probes included on the array tube that did not hybridize to
any of the clinical isolates are the ones for the two Shiga toxins
(stx1 and stx2), the two heat-labile toxins (eltI and eltII), the
heat-stable toxins (stIA and stIB), the aggregative adhesion
fimbria (aafI), the bundle forming pilus (bfpA), the coloniza-
tion factor antigens I, II, and III (cfa, CS3, cof), the intimin
(eaeA), the invasion plasmid antigen (ipaH), the enterohem-
orrhagic E. coli hemolysin (ehxA), the longus pilus (lng), the
cytolethal distending toxin (cdt), as well as the gene probes for
the K88 and K99 fimbrial antigens.
DISCUSSION
We present the development of a diagnostic microarray test,
its evaluation and validation as well as the application of this
user-friendly tool for screening a series of E. coli strains asso-
ciated with newborn meningitis. By applying the established
array tube, we were able to carry out a comprehensive analysis
of K1 and related strains concerning their virulence gene pro-
file. Several studies have described the presence of specific
genes in K1 strains, however, these were restricted to PCR
detection of genes known to be present in such strains or
focusing on virulence factors specific for extraintestinal patho-
types. This is the first time such strains were analyzed for the
presence of multiple virulence genes specific for extraintestinal
as well as intestinal pathotypes of E. coli. The array tube
includes positive control probes, of which the probe for the 16S
rRNA (rrs) is universal. The second control for type 1 fimbriae
(fimA), which can be found on average in about 70% of E. coli
strains, including nonpathogenic strains (21), was positive for
all the isolates. The gene fhuA, indicating an iron transport
system present in most E. coli strains, showed positive signals
for only 78% of the isolates. The one strain which did not
hybridize to any of the virulence genes was isolated from the
cerebrospinal fluid of a neonate who presented bacterial men-
ingitis with clinical sepsis. However, the absence of virulence
genes in this strain suggests that the isolate might represent a
contaminant from sampling.
Looking at specific virulence genes, we found the K1 deter-
minant in 88% of our strains. In order to validate the microar-
ray test for typing of K1, we agglutinated all the strains with a
K1 antiserum. There was a perfect correlation of the K1 phe-
notype and genotype, indicating that the probe used on the
array tube is highly specific for K1 strains.
A series of probes for fimbriae of uropathogenic E. coli were
included on the array tube. Such fimbrial genes were found to
be very common, since one or more of them could be detected
in 85% of the strains. The prevalence of the P and S fimbrial
genes was generally higher than described by phenotypic meth-
ods (22). In 65%, 48%, and 35% of strains, we found genes for
P, F1C, and S fimbriae, respectively. This difference can be
explained by the lack of expression of fimbriae in certain
strains analyzed phenotypically. In fact, Bingen et al. (5), with
PCR, showed a similar genetic prevalence, with pap being
higher than sfa.
Several strains contained the two toxin genes hlyA and cnf.
Hemolysin production was described by others in 25% of the
strains (22), in agreement with the 23% of strains where we
found the gene for the -hemolysin. The cytotoxic necrotizing
factor is known to contribute to the virulence of K1 strains,
allowing penetration of the blood-brain barrier (18). We found
cnf in six strains (15%), and one of them was a non-K1 isolate.
This rather low prevalence of cnf questions its importance and
indicates that other factors like the K1 capsule itself or the Ibe
protein (not included on the array tube) contributes to the
invasion of the central nervous system (20).
Iron acquisition systems are important for septicemic E. coli
strains, in order to enable the strains to access iron under
iron-limited conditions in the blood. Therefore it is not sur-
prising that all strains except one have a high-efficiency iron
acquisition system. The gene for the hemin receptor (chuA) is
predominantly present in 95% of the strains. The siderophore
aerobactin, represented by the iucC probe, is less prevalent and
found in 50% of the strains. Interestingly, 19 out of 20 strains
having the aerobactin system also contain the chuA gene.
Negre et al. (26) hypothesized that the hemin transport system
could act as a “backup” system for iron acquisition. This could
explain the high prevalence of this gene and the presence of
additional iron acquisition systems in some strains. All strains
that contained the -hemolysin also contained chuA, indicating
a synergistic action of the hemolysin with the hemin receptor.
In one of the non-K1 strains we could detect the gene indi-
cating the presence of a K5 capsule. This strain was otherwise
very similar to the others, having uropathogenic E. coli-specific
fimbrial genes as well as the chuA gene. This strain was isolated
from a placental swab in a neonate who presented with culture-
proven E. coli sepsis (without meningitis, and recovery from
the infection after 21 days of therapy).
Virulence genes characteristic of intestinal E. coli were typ-
ically absent in the strains analyzed. Given the common habitat
of the gut, a genetic exchange of such genes could be expected.
It was therefore somewhat surprising that few of them were
found in our strains. In fact, only two strains showed the pres-
ence of the O157 catalase gene and the gene for the small
heat-stable toxin AstA, respectively. These positive hybridiza-
tion signals were confirmed by PCR. Both genes are located on
plasmids and therefore relatively easy transfer could be antic-
ipated (9, 37). However, in the case of the O157 catalase, which
is located on the pO157 plasmid, no other virulence genes
found on this plasmid (e.g., the enterohemorrhagic E. coli
hemolysin) were detected in this strain.
Six strains representing five different virulence gene patterns
show linkage of hlyA, pap, and cnf. These genes are located on
pathogenicity island PAIII of uropathogenic E. coli strain J96
(28). In fact there are indications of pathogenicity island in-
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volvement in certain neonatal meningitis-causing E. coli, and
for one strain the presence of a pathogenicity island similar to
PAIII of J96 was postulated (8, 14). Our findings show that this
pathogenicity island is distributed among K1 and related E. coli
strains.
The observation of so many different virulence gene patterns
for K1 strains is an indication that they constitute a rather
heterogeneous group of E. coli strains. Similarly, Mu¨hldorfer
et al. (25), with colony hybridization with fewer gene probes,
found 10 different virulence gene patterns in K1 strains iso-
lated from the stools of healthy volunteers. This broad variety
of E. coli K1 was also observed in a study of Achtman et al. (1)
with several classical typing techniques. It is clear that many
E. coli K1 clones have the potential of causing meningitis,
which reflects the commensal nature of K1 strains (25). How-
ever, some clones seem to be less virulent than others, and the
predominance of clonal groups may vary geographically (2).
Up to 40% of healthy individuals are carriers of such strains
that are recovered from the feces, urinary tract, and vagina (27,
36). Therefore, a broad variety of isolates could be expected,
considering the ecological niches these strains live in and have
been described by others, including form variation, serotype,
genetic relationship, and distribution of extraintestinal viru-
lence genes (16, 22, 30, 32, 39).
The array tube combines the advantage of the classical mi-
croarray technique, allowing parallel detection of large num-
bers of genes, with an easily manageable and cost-efficient
system. The Eppendorf tube format allows easy pipetting, han-
dling, and reading of the hybridization signals, for which con-
ventional laboratory equipment can be used, in contrast to the
glass slide format. The use of biotin-labeled nucleotides in the
array tube assay is more sensitive than comparable Cy3-based
detection used on glass slides (24). With the array tube, a single
analysis of a strain can be achieved in less than 48 h, and
several strains can be processed in parallel. The small amount
of DNA used in labeling would even allow the testing of pa-
tient samples rather than overnight cultures. This in combina-
tion with an optimized hybridization protocol of less that 2 h
(as they exist for oligo-based array tubes) will further cut down
analysis time to a few hours (24).
Furthermore, there are several advantages of the array tube
over PCR, including real-time PCR. The parallel detection of
numerous genes can be achieved in a single experiment. In
order to get the same coverage of the 32 E. coli virulence genes
in triplicate as on the array tube, 96 PCR tests would have been
necessary for analyzing a single strain. It is obvious that this is
much more work and cost intensive than running a single array
tube. Moreover, PCR is prone to contamination, which is al-
most impossible with the array tube system. Therefore, ex-
treme precaution, including physical separation of PCR pro-
cesses, is not needed with the tubes. Furthermore, the array
tube allows the detection of variants of E. coli virulence genes
by hybridization. A sequence variation in one or both PCR
primers would lead to negative results in a PCR-based detec-
tion method.
In summary, the array tube detection system proved to be a
helpful diagnostic tool for genetic typing of K1 strains as well
as other pathogenic E. coli strains. Given the open platform,
this prototype of an E. coli virulence gene detection system can
be easily optimized, and new gene probes can be included in
the future (e.g., newly described virulence or antibiotic resis-
tance genes).
ACKNOWLEDGMENTS
We thank Ines Leube for technical help and Ulrich Certa for valu-
able discussions.
This work was supported by a grant from the KTI (no. 6041.1 KTS)
and the research fund of the Institute of Veterinary Bacteriology,
Bern.
REFERENCES
1. Achtman, M., A. Mercer, B. Kusecek, A. Pohl, M. Heuzenroeder, W. Aaron-
son, A. Sutton, and R. P. Silver. 1983. Six widespread bacterial clones among
Escherichia coli K1 isolates. Infect. Immun. 39:315–335.
2. Achtman, M., and G. Pluschke. 1986. Clonal analysis of descent and viru-
lence among selected Escherichia coli. Annu. Rev. Microbiol. 40:185–210:
185–210.
3. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990.
Basic logical alignment search tool. J. Mol. Biol. 215:403–410.
4. Bekal, S., R. Brousseau, L. Masson, G. Prefontaine, J. Fairbrother, and J.
Harel. 2003. Rapid identification of Escherichia coli pathotypes by virulence
gene detection with DNA microarrays. J. Clin. Microbiol. 41:2113–2125.
5. Bingen, E., S. Bonacorsi, N. Brahimi, E. Denamur, and J. Elion. 1997.
Virulence patterns of Escherichia coli K1 strains associated with neonatal
meningitis. J. Clin. Microbiol. 35:2981–2982.
6. Blum, G., M. Ott, A. Lischewski, A. Ritter, H. Imrich, H. Tscha¨pe, and J.
Hacker. 1994. Excision of large DNA regions termed pathogenicity islands
from tRNA-specific loci in the chromosome of an Escherichia coli wild-type
pathogen. Infect. Immun. 62:606–614.
7. Bohlander, S. K., R. Espinosa, III, M. M. Le Beau, J. D. Rowley, and M. O.
Diaz. 1992. A method for the rapid sequence-independent amplification of
microdissected chromosomal material. Genomics 13:1322–1324.
8. Bonacorsi, S. P., O. Clermont, C. Tinsley, G. Le, I., J. C. Beaudoin, J. Elion,
X. Nassif, and E. Bingen. 2000. Identification of regions of the Escherichia
coli chromosome specific for neonatal meningitis-associated strains. Infect.
Immun. 68:2096–2101.
9. Brunder, W., H. Schmidt, and H. Karch. 1996. KatP, a novel catalase-
peroxidase encoded by the large plasmid of enterohemorrhagic Escherichia
coli O157:H7. Microbiology 142:3305–3315.
10. Dobrindt, U., F. Agerer, K. Michaelis, A. Janka, C. Buchrieser, M. Samuel-
son, C. Svanborg, G. Gottschalk, H. Karch, and J. Hacker. 2003. Analysis of
genome plasticity in pathogenic and commensal Escherichia coli isolates by
use of DNA arrays. J. Bacteriol. 185:1831–1840.
11. Gyles, C. L. 1994. Escherichia coli in domestic animals and humans. CAB
International, Wallingford, England.
12. Hacker, J., G. Blum-Oehler, I. Mu¨hldorfer, and H. Tscha¨pe. 1997. Patho-
genicity islands of virulent bacteria: structure, function and impact on mi-
crobial evolution. Mol. Microbiol. 23:1089–1097.
13. Harvey, D., D. E. Holt, and H. Bedford. 1999. Bacterial meningitis in the
newborn: a prospective study of mortality and morbidity. Semin. Perinatol.
23:218–225.
14. Houdouin, V., S. Bonacorsi, N. Brahimi, O. Clermont, X. Nassif, and E.
Bingen. 2002. A uropathogenicity island contributes to the pathogenicity of
Escherichia coli strains that cause neonatal meningitis. Infect. Immun. 70:
5865–5869.
15. Janka, A., M. Bielaszewska, U. Dobrindt, L. Greune, M. A. Schmidt, and H.
Karch. 2003. Cytolethal distending toxin gene cluster in enterohemorrhagic
Escherichia coli O157:H- and O157:H7: characterization and evolutionary
considerations. Infect. Immun. 71:3634–3638.
16. Johnson, J. R., E. Oswald, T. T. O’Bryan, M. A. Kuskowski, and L. Span-
jaard. 2002. Phylogenetic distribution of virulence-associated genes among
Escherichia coli isolates associated with neonatal bacterial meningitis in the
Netherlands. J. Infect. Dis. 185:774–784.
17. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia
coli. Nat. Rev. Microbiol. 2:123–140.
18. Khan, N. A., Y. Wang, K. J. Kim, J. W. Chung, C. A. Wass, and K. S. Kim.
2002. Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 inva-
sion of the central nervous system. J. Biol. Chem. 277:15607–15612.
19. Kim, K. S. 2001. Escherichia coli translocation at the blood-brain barrier.
Infect. Immun. 69:5217–5222.
20. Kim, K. S. 2002. Strategy of Escherichia coli for crossing the blood-brain
barrier. J. Infect. Dis. 186(Suppl. 2):S220–S224.
21. Klemm, P. 1984. The fimA gene encoding the type-1 fimbrial subunit of
Escherichia coli. Nucleotide sequence and primary structure of the protein.
Eur. J. Biochem. 143:395–399.
22. Korhonen, T. K., M. V. Valtonen, J. Parkkinen, V. Vaisanen-Rhen, J. Finne,
F. Orskov, I. Orskov, S. B. Svenson, and P. H. Makela. 1985. Serotypes,
hemolysin production, and receptor recognition of Escherichia coli strains
associated with neonatal sepsis and meningitis. Infect. Immun. 48:486–491.
1030 KORCZAK ET AL. J. CLIN. MICROBIOL.
23. Kuhnert, P., J. Hacker, I. Mu¨hldorfer, A. P. Burnens, J. Nicolet, and J. Frey.
1997. Detection system for Escherichia coli-specific virulence genes: Absence
of virulence determinants in B and C strains. Appl. Environ. Microbiol.
63:703–709.
24. Monecke, S., I. Leube, and R. Ehricht. 2003. Simple and robust array-based
methods for the parallel detection of resistance genes of Staphylococcus
aureus. Genome Lett. 2:106–118.
25. Mu¨hldorfer, I., G. Blum, A. Donohue-Rolfe, H. Heier, T. O¨lschla¨ger, H.
Tscha¨pe, U. Wallner, and J. Hacker. 1996. Characterization of Escherichia
coli strains isolated from environmental water habitats and from stool sam-
ples of healthy volunteers. Res. Microbiol. 147:625–635.
26. Negre, V. L., S. Bonacorsi, S. Schubert, P. Bidet, X. Nassif, and E. Bingen.
2004. The siderophore receptor IroN, but not the high-pathogenicity island
or the hemin receptor ChuA, contributes to the bacteremic step of Esche-
richia coli neonatal meningitis. Infect. Immun. 72:1216–1220.
27. Obata-Yasuoka, M., W. Ba-Thein, T. Tsukamoto, H. Yoshikawa, and H.
Hayashi. 2002. Vaginal Escherichia coli share common virulence factor pro-
files, serotypes and phylogeny with other extraintestinal E. coli. Microbiology
148:2745–2752.
28. Oelschlaeger, T. A., U. Dobrindt, and J. Hacker. 2002. Pathogenicity islands
of uropathogenic E. coli and the evolution of virulence. Int. J. Antimicrob.
Agents 19:517–521.
29. Orskov, F., and I. Orskov. 1984. Serotyping of Escherichia coli. Methods
Microbiol. 14:43–112.
30. Orskov, F., I. Orskov, A. Sutton, R. Schneerson, W. Lin, W. Egan, G. E. Hoff,
and J. B. Robbins. 1979. Form variation in Escherichia coli K1: determined
by O-acetylation of the capsular polysaccharide. J. Exp. Med. 149:669–685.
31. Ott, M. 1993. Dynamics of the bacterial genome-deletions and integrations
as mechanisms of bacterial virulence modulation. Zbl. Bakteriol. Int. J. Med.
Microbiol. 278:457–468.
32. Ott, M., L. Bender, G. Blum, M. Schmittroth, M. Achtman, H. Tscha¨pe, and
J. Hacker. 1991. Virulence patterns and long-range genetic mapping of
extraintestinal Escherichia coli K1, K5, and K100 isolates: use of pulsed-field
gel electrophoresis. Infect. Immun. 59:2264–2672.
33. Pitcher, D. G., N. A. Saunders, and R. J. Owen. 1989. Rapid extraction of
bacterial genomic DNA with guanidinium thiocyanate. Lett. Appl. Micro-
biol. 8:151–156.
34. Pong, A., and J. S. Bradley. 1999. Bacterial meningitis and the newborn
infant. Infect. Dis. Clin. North Am. 13:711–733.
35. Quagliarello, V., and W. M. Scheld. 1992. Bacterial meningitis: pathogenesis,
pathophysiology, and progress. N. Engl. J. Med. 327:864–872.
36. Sarff, L. D., G. H. McCracken, M. S. Schiffer, M. P. Glode, J. B. Robbins, I.
Orskov, and F. Orskov. 1975. Epidemiology of Escherichia coli K1 in healthy
and diseased newborns. Lancet i:1099–1104.
37. Savarino, S. J., A. McVeigh, J. Watson, A. Cravioto, J. Molina, P. Echever-
ria, M. K. Bhan, M. M. Levine, and A. Fasano. 1996. Enteroaggregative
Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative
E-coli. J. Infect. Dis. 173:1019–1022.
38. Schubert, S., A. Rakin, H. Karch, E. Carniel, and J. Heesemann. 1998.
Prevalence of the “high-pathogenicity island” of Yersinia species among
Escherichia coli strains that are pathogenic to humans. Infect. Immun. 66:
480–485.
39. Selander, R. K., T. K. Korhonen, V. Vaisanen-Rhen, P. H. Williams, P. E.
Pattison, and D. A. Caugant. 1986. Genetic relationships and clonal struc-
ture of strains of Escherichia coli causing neonatal septicemia and meningitis.
Infect. Immun. 52:213–222.
40. Stoll, B. J. 1997. The global impact of neonatal infection. Clin. Perinatol.
24:1–21.
41. Unhanand, M., M. M. Mustafa, G. H. McCracken, Jr., and J. D. Nelson.
1993. Gram-negative enteric bacillary meningitis: a twenty-one-year experi-
ence. J. Pediatr. 122:15–21.
42. Van Ijperen, C., P. Kuhnert, J. Frey, and J. Clewely. 2002. Virulence typing
of Escherichia coli using microarrays. Mol. Cell. Probes 16:371–378.
VOL. 43, 2005 VIRULENCE PATTERNS OF E. COLI K1 1031
